Valeritas inks Middle East distro deal for V-Go insulin delivery device

Valeritas (NSDQ:VLRX) said today that it signed an exclusive distribution deal with Julphar for the commercialization of its V-Go wearable insulin delivery device in the member states of the Gulf Cooperation Council. Valeritas has deals in place to bring its V-Go device to 14 countries and territories, including Australia, Slovenia and Puerto Rico. The company is also working to win regulatory approval for the product in China. Get the full story at our sister site, Drug Delivery Business News. The post Valeritas inks Middle East distro deal for V-Go insulin delivery device appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Diabetes Distribution Drug-Device Combinations Pharmaceuticals Wall Street Beat Valeritas Source Type: news

Related Links:

Publication date: 5 December 2020Source: Journal of Molecular Structure, Volume 1221Author(s): Hossein Fasihi Dastjerdi, Nima Naderi, Manijeh Nematpour, Elham Rezaee, Mohammad Mahboubi-Rabbani, Melika Ebrahimi, Samaneh Hosseinipoor, Omid Hosseini, Sayyed Abbas Tabatabai
Source: Journal of Molecular Structure - Category: Molecular Biology Source Type: research
CONCLUSIONS: For public health issue with type2 diabetes and infection, DPP4i use decreased KP pneumonia. Male gender, patients with co-morbidities, patients with higher DSCI score and higher DDD of DPP4i were observed to decrease KP pneumonia infection in our analysis. The possible role of DPP4i causing immunological disturbances should be considered. PMID: 32633173 [PubMed - as supplied by publisher]
Source: Postgraduate Medicine - Category: Internal Medicine Tags: Postgrad Med Source Type: research
Authors: Mphwanthe G, Weatherspoon D, Kalimbira A, Weatherspoon L Abstract We assessed glycemic status and associations with socio-demographic, biomedical, anthropometric, and physical activity (PA) levels among adults with type 2 diabetes mellitus (T2DM) (n = 428; urban n = 288; semi-urban n = 140) using a cross-sectional study. Multivariate linear regression was used to determine factors associated with glycosylated hemoglobin (A1C) . A1C was clinically elevated ≥8% for 60.3% of the participants. Overall, age and PA levels showed a negative association with A1C, and positively with underwei...
Source: Social Work in Public Health - Category: International Medicine & Public Health Tags: Soc Work Public Health Source Type: research
This study aims to evaluate the impact of excess body weight, diabetes mellitus, and hypertension on the nutritional composition of human milk. This cohort study was conducted at a tertiary public health unit in the city of Rio de Janeiro from March 2016 to February 2018. The data were collected in two stages (96 hours and one month after delivery). The macronutrients (carbohydrate, protein, lipid) and total energy were determined using the MIRIS® equipment. The level of significance was 5%. Higher protein content was observed in the nutritional composition of colostrum in women with diabetes mellitus. A higher ...
Source: International Journal of Food Sciences and Nutrition - Category: Nutrition Tags: Int J Food Sci Nutr Source Type: research
Condition:   Nonalcoholic Steatohepatitis Intervention:   Sponsor:   University of California, San Diego Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Respiratory Diseases;   Neurological Disorders;   Type 1 Diabetes Interventions:   Diagnostic Test: Real-time SESI-MS breath analysis;   Diagnostic Test: Off-line breath analysis;   Diagnostic Test: Blood analysis;   Diagnostic Test: Saliva analysis;   Diagnostic Test: Urine analysis Sponsors:   University Children's Hospital Basel;   Swiss National Science Foundation;   Fondation Botnar (Switzerland) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Type II Diabetes;   Primary Health Care;   Behavioral Health Intervention:   Behavioral: INTEGRATE-D Sponsor:   Oregon Health and Science University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Type 2 Diabetes Interventions:   Dietary Supplement: Oral Supplement;   Dietary Supplement: Placebo Sponsor:   Texas A&M  University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Cardiovascular Diseases;   Left Ventricular Hypertrophy Interventions:   Drug: Empagliflozin;   Drug: Placebo Sponsors:   St. Michael's Hospital, Toronto;   Canadian Medical and Surgical Knowledge Translation Research Group;   Boehringer Ingelheim;   Applied Health Research Centre Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Insulin icodec;   Drug: Insulin glargine Sponsor:   Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Australia Health | China Health | Diabetes | Endocrinology | Insulin | Middle East Health | Slovenia Health